Reply: To PMID 24002804

Affiliations

¹ Departments of Oncology, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

Comment

Chiun Hsu et al. Hepatology. 2014 Aug.

. 2014 Aug;60(2):766-7.

doi: 10.1002/hep.26961. Epub 2014 Jun 18.

¹ Departments of Oncology, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

No abstract available

Comment on

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group. Hsu C, et al. Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14. Hepatology. 2014. PMID: 24002804
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy.
Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Kusumoto S, et al. Hepatology. 2014 Aug;60(2):765-6. doi: 10.1002/hep.26963. Epub 2014 Jun 18. Hepatology. 2014. PMID: 24347499 No abstract available.